UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
European urology, ISSN 0302-2838, 2014, Volume 68, Issue 3, pp. 428 - 435
Urology | Epididymitis | Guideline recommendations | Antimicrobial therapy | Sexually transmitted infections | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | DNA, Ribosomal | Humans | Middle Aged | Male | Anti-Bacterial Agents - therapeutic use | Enterovirus Infections - epidemiology | Enterovirus - genetics | Enterovirus Infections - virology | Epididymitis - drug therapy | Polymerase Chain Reaction | Chlamydia Infections - drug therapy | Adult | Escherichia coli Infections - drug therapy | Chlamydia trachomatis - genetics | Mycoplasma Infections - microbiology | Epididymitis - epidemiology | Mycoplasma - genetics | Escherichia coli Infections - microbiology | Chlamydia Infections - epidemiology | Mycoplasma Infections - drug therapy | Epididymitis - microbiology | Germany - epidemiology | Escherichia coli Infections - epidemiology | Chlamydia Infections - microbiology | DNA, Bacterial - genetics | Molecular Epidemiology | Escherichia coli - genetics | Aged | Mycoplasma Infections - epidemiology | Enterococcus - genetics | Practice Guidelines as Topic | Causes and theories of causation | Diseases | Index Medicus
Journal Article
Antiviral research, ISSN 0166-3542, 06/2017, Volume 142, pp. 148 - 157
Enveloped virus | Viral binding | Curcumin | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Virology | Zika Virus Infection - drug therapy | Zika Virus - genetics | Chikungunya virus - genetics | Enterovirus - drug effects | Curcumin - chemistry | Humans | Vesicular stomatitis Indiana virus - drug effects | Cercopithecus aethiops | Curcumin - administration & dosage | Virus Internalization - drug effects | Dose-Response Relationship, Drug | Inhibitory Concentration 50 | Vero Cells | Cell Line | Cell Survival - drug effects | Virus Replication - drug effects | Antiviral Agents - pharmacology | Chikungunya Fever - drug therapy | Curcumin - pharmacology | Zika Virus - drug effects | Coxsackievirus Infections - drug therapy | Virus Attachment - drug effects | Chikungunya virus - drug effects | Animals | HeLa Cells | RNA, Viral - drug effects | Virus diseases | Antiviral agents | Medicine, Botanic | Dengue viruses | Food additives | Dietary supplements | Medicine, Herbal | Hepatitis C virus | Coxsackievirus infections | Health aspects | Cells | Mosquitoes | Monoglycerides | Index Medicus
Journal Article
Virology (New York, N.Y.), ISSN 0042-6822, 01/2019, Volume 526, pp. 146 - 154
Enterovirus D68 | Animal model | Respiratory disease | Guanidine | Antiviral | Neurological disease | Acute flaccid myelitis | Life Sciences & Biomedicine | Science & Technology | Virology | Humans | Male | Enterovirus Infections - physiopathology | Lung - virology | Enterovirus Infections - virology | Enterovirus D, Human | Guanidine - therapeutic use | Female | Lung - metabolism | Nervous System Diseases - physiopathology | Respiratory Tract Infections - virology | Respiratory Tract Infections - physiopathology | Disease Models, Animal | Nervous System Diseases - pathology | Respiratory Tract Infections - pathology | Enterovirus Infections - drug therapy | Lung - pathology | Cytokines - metabolism | Antiviral Agents - therapeutic use | Nervous System Diseases - drug therapy | Respiratory Tract Infections - drug therapy | Treatment Outcome | Lung - physiopathology | Animals | Viremia - prevention & control | Nervous System Diseases - virology | Mice | Enterovirus Infections - pathology | Viral Load - drug effects | Virus diseases | Antiviral agents | Nervous system diseases | Analysis | Models | Paralysis | Health aspects | Index Medicus | Neurological Disease | Animal Model | Respiratory Disease | Acute Flaccid Myelitis
Journal Article
Seminars in hematology, ISSN 0037-1963, 2010, Volume 47, Issue 2, pp. 187 - 198
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Hematology | Science & Technology | Lymphoma, Non-Hodgkin - immunology | Pneumonia, Pneumocystis - etiology | JC Virus - immunology | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | JC Virus - physiology | Postoperative Complications - immunology | Infection - etiology | Parvovirus B19, Human - immunology | Meningoencephalitis - immunology | Hepatitis B - complications | Hepatitis B - immunology | Enterovirus Infections - virology | Lymphoma, Non-Hodgkin - complications | Antineoplastic Agents - adverse effects | Parvovirus B19, Human - physiology | Antineoplastic Agents - pharmacology | Hepatitis B virus - immunology | Immunosuppressive Agents - pharmacology | Postoperative Complications - chemically induced | Autoimmune Diseases - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Leukoencephalopathy, Progressive Multifocal - immunology | Enterovirus Infections - etiology | Antibodies, Monoclonal, Murine-Derived | Disease Susceptibility | Infection - immunology | Antibodies, Monoclonal - pharmacology | Graft Rejection - prevention & control | Risk Factors | Autoimmune Diseases - complications | Autoimmune Diseases - immunology | Rituximab | Hepatitis B virus - physiology | Virus Activation - drug effects | Meningoencephalitis - virology | HIV Infections - complications | Immunosuppressive Agents - adverse effects | Immunocompromised Host | Leukoencephalopathy, Progressive Multifocal - complications | Index Medicus
Journal Article
Antiviral research, ISSN 0166-3542, 02/2013, Volume 97, Issue 2, pp. 183 - 194
Picornavirus | Enterovirus 71 | Antiviral therapy | Enterovirus | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Virology | Antiviral agents | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Antiviral Agents - pharmacology | Encephalitis, Viral - virology | Humans | Drug Discovery - trends | Drug Discovery - methods | China - epidemiology | Asia, Southeastern - epidemiology | Enterovirus A, Human - drug effects | Hand, Foot and Mouth Disease - epidemiology | Hand, Foot and Mouth Disease - complications | Antiviral Agents - isolation & purification | Hand, Foot and Mouth Disease - virology | Encephalitis, Viral - epidemiology | Children | Drug therapy | Coxsackievirus infections | Diseases | Index Medicus | Infection | Aseptic meningitis | Encephalitis | Epidemics | RNA viruses | Central nervous system | Foot-and-mouth disease | Infants | Drug discovery | Vaccines | Hand
Journal Article
Clinical research in cardiology, ISSN 1861-0684, 9/2016, Volume 105, Issue 9, pp. 763 - 773
Chronic viral cardiomyopathy | Medicine & Public Health | Antiviral therapy, myocardial biopsies | Cardiology | Interferon beta | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Adenoviridae Infections - drug therapy | Adenoviridae Infections - virology | Humans | Middle Aged | Male | Enterovirus Infections - physiopathology | Recovery of Function | Viral Load | Cardiomyopathies - physiopathology | Adenoviridae Infections - physiopathology | Enterovirus Infections - virology | Erythema Infectiosum - physiopathology | Time Factors | Cardiomyopathies - diagnosis | Erythema Infectiosum - diagnosis | Adult | Female | Erythema Infectiosum - virology | Cardiomyopathies - drug therapy | Enterovirus Infections - drug therapy | Enterovirus Infections - diagnosis | Double-Blind Method | Antiviral Agents - therapeutic use | Europe | Treatment Outcome | Erythema Infectiosum - drug therapy | Adenoviridae Infections - diagnosis | Interferon beta-1b - adverse effects | Cardiomyopathies - virology | Biopsy | Antiviral Agents - adverse effects | Interferon beta-1b - therapeutic use | Quality of Life | Aged | Chronic Disease | Index Medicus
Journal Article
Seminars in perinatology, ISSN 0146-0005, 04/2018, Volume 42, Issue 3, pp. 191 - 197
Neonatal infection | Capsid inhibitors | Nonpolio enterovirus(es) | Parechovirus(es) | Pediatrics | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Enterovirus Infections - congenital | Enterovirus Infections - drug therapy | Enterovirus Infections - diagnosis | Parechovirus - genetics | Antiviral Agents - therapeutic use | Picornaviridae Infections - drug therapy | Pregnancy Complications, Infectious - epidemiology | Humans | Infectious Disease Transmission, Vertical | Picornaviridae Infections - diagnosis | Cross Infection - drug therapy | Oxadiazoles - therapeutic use | Pregnancy | Enterovirus Infections - epidemiology | Fomites | Enterovirus - genetics | Picornaviridae Infections - epidemiology | Phenyl Ethers - therapeutic use | Picornaviridae Infections - congenital | Polymerase Chain Reaction | Cross Infection - diagnosis | Female | Infant, Newborn | Cross Infection - epidemiology | Virus diseases | Infants (Newborn) | Medical colleges | Bacterial infections | Virus diseases in children | Septic shock | Children | Health aspects | Epidemiology | Diseases | Index Medicus
Journal Article
Current opinion in pharmacology, ISSN 1471-4892, 12/2018, Volume 43, pp. 11 - 19
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Enterovirus - drug effects | Humans | Insulin-Secreting Cells - metabolism | Enterovirus Infections - virology | Enterovirus Infections - immunology | Drug Design | Diabetes Mellitus, Type 1 - immunology | Enterovirus Infections - blood | Enterovirus Infections - drug therapy | Hypoglycemic Agents - therapeutic use | Diabetes Mellitus, Type 1 - virology | Antiviral Agents - therapeutic use | Risk Factors | Biomarkers - blood | Insulin-Secreting Cells - immunology | Diabetes Mellitus, Type 1 - drug therapy | Blood Glucose - drug effects | Host-Pathogen Interactions | Enterovirus - pathogenicity | Animals | Insulin-Secreting Cells - drug effects | Insulin-Secreting Cells - virology | Antiviral Agents - adverse effects | Diabetes Mellitus, Type 1 - blood | Blood Glucose - metabolism | Hypoglycemic Agents - adverse effects | Autoimmunity | Medical research | Pancreatic beta cells | Type 1 diabetes | Medicine, Experimental | Health aspects | Epidemiology | Spyware | Index Medicus
Journal Article